The ADC binds HER2 on tumor cells and is internalized; linker cleavage releases MMAE, which binds β‑tubulin to disrupt microtubules, causing G2/M arrest and apoptosis. Killing is directed by HER2 targeting (with possible bystander effect), not by β‑tubulin expression itself.